AU4770400A - Fused polycyclic amino acids as pharmaceutical agents - Google Patents
Fused polycyclic amino acids as pharmaceutical agentsInfo
- Publication number
- AU4770400A AU4770400A AU47704/00A AU4770400A AU4770400A AU 4770400 A AU4770400 A AU 4770400A AU 47704/00 A AU47704/00 A AU 47704/00A AU 4770400 A AU4770400 A AU 4770400A AU 4770400 A AU4770400 A AU 4770400A
- Authority
- AU
- Australia
- Prior art keywords
- amino acids
- pharmaceutical agents
- fused polycyclic
- polycyclic amino
- fused
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000008177 pharmaceutical agent Substances 0.000 title 1
- -1 polycyclic amino acids Chemical class 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/14—Benz[f]indenes; Hydrogenated benz[f]indenes
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13610099P | 1999-05-26 | 1999-05-26 | |
| US60136100 | 1999-05-26 | ||
| PCT/GB2000/001819 WO2000073259A1 (en) | 1999-05-26 | 2000-05-12 | Fused polycyclic amino acids as pharmaceutical agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU4770400A true AU4770400A (en) | 2000-12-18 |
Family
ID=22471297
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU47704/00A Abandoned AU4770400A (en) | 1999-05-26 | 2000-05-12 | Fused polycyclic amino acids as pharmaceutical agents |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1180094B1 (enExample) |
| JP (1) | JP2003500466A (enExample) |
| AT (1) | ATE272048T1 (enExample) |
| AU (1) | AU4770400A (enExample) |
| BR (1) | BR0010961A (enExample) |
| CA (1) | CA2373210A1 (enExample) |
| DE (1) | DE60012508T2 (enExample) |
| DK (1) | DK1180094T3 (enExample) |
| ES (1) | ES2228524T3 (enExample) |
| HK (1) | HK1040237B (enExample) |
| MX (1) | MXPA01011955A (enExample) |
| PT (1) | PT1180094E (enExample) |
| WO (1) | WO2000073259A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005539092A (ja) * | 2002-08-15 | 2005-12-22 | ファイザー・インク | 縮合二環式または三環式アミノ酸の治療における使用 |
| EP1820502A1 (en) | 2006-02-10 | 2007-08-22 | Laboratorios Del Dr. Esteve, S.A. | Active substance combination comprising azolylcarbinol compounds |
| EP2116539A1 (en) | 2008-04-25 | 2009-11-11 | Laboratorios Del. Dr. Esteve, S.A. | 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof |
| EP2353598A1 (en) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for use in the prevention and/or treatment of postoperative pain |
| EP2353591A1 (en) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof |
| EP2388005A1 (en) | 2010-05-21 | 2011-11-23 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy |
| EP2415471A1 (en) | 2010-08-03 | 2012-02-08 | Laboratorios Del. Dr. Esteve, S.A. | Use of sigma ligands in opioid-induced hyperalgesia |
| EP2524694A1 (en) | 2011-05-19 | 2012-11-21 | Laboratorios Del. Dr. Esteve, S.A. | Use of sigma ligands in diabetes type-2 associated pain |
| SG11201604478UA (en) | 2013-12-17 | 2016-07-28 | Esteve Labor Dr | Gabapentinoids and sigma receptor ligands combinations |
| SG11201604480PA (en) | 2013-12-17 | 2016-07-28 | Esteve Labor Dr | SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIs) AND SIGMA RECEPTOR LIGANDS COMBINATIONS |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2164054T3 (es) * | 1991-11-05 | 2002-02-16 | Smithkline Beecham Corp | Antagonistas de receptores de endotelina. |
| DE69737719D1 (de) * | 1996-10-23 | 2007-06-21 | Warner Lambert Co | Substituierte gamma-aminobuttersäurederivate als arzneimittel |
| BR9813284B1 (pt) * | 1997-10-27 | 2012-08-21 | aminoácidos cìclicos e derivados dos mesmos úteis como agentes farmacêuticos e composição farmacêutica. |
-
2000
- 2000-05-12 EP EP00929701A patent/EP1180094B1/en not_active Expired - Lifetime
- 2000-05-12 DE DE60012508T patent/DE60012508T2/de not_active Expired - Fee Related
- 2000-05-12 BR BR0010961-4A patent/BR0010961A/pt not_active Application Discontinuation
- 2000-05-12 DK DK00929701T patent/DK1180094T3/da active
- 2000-05-12 AT AT00929701T patent/ATE272048T1/de not_active IP Right Cessation
- 2000-05-12 ES ES00929701T patent/ES2228524T3/es not_active Expired - Lifetime
- 2000-05-12 CA CA002373210A patent/CA2373210A1/en not_active Abandoned
- 2000-05-12 AU AU47704/00A patent/AU4770400A/en not_active Abandoned
- 2000-05-12 HK HK02101978.2A patent/HK1040237B/en not_active IP Right Cessation
- 2000-05-12 PT PT00929701T patent/PT1180094E/pt unknown
- 2000-05-12 JP JP2000621326A patent/JP2003500466A/ja active Pending
- 2000-05-12 WO PCT/GB2000/001819 patent/WO2000073259A1/en not_active Ceased
- 2000-05-12 MX MXPA01011955A patent/MXPA01011955A/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| HK1040237A1 (en) | 2002-05-31 |
| MXPA01011955A (es) | 2003-09-04 |
| ES2228524T3 (es) | 2005-04-16 |
| DE60012508T2 (de) | 2005-06-23 |
| DK1180094T3 (da) | 2004-11-01 |
| HK1040237B (en) | 2004-12-31 |
| DE60012508D1 (de) | 2004-09-02 |
| JP2003500466A (ja) | 2003-01-07 |
| ATE272048T1 (de) | 2004-08-15 |
| CA2373210A1 (en) | 2000-12-07 |
| EP1180094B1 (en) | 2004-07-28 |
| EP1180094A1 (en) | 2002-02-20 |
| PT1180094E (pt) | 2004-10-29 |
| WO2000073259A1 (en) | 2000-12-07 |
| BR0010961A (pt) | 2002-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9914486D0 (en) | Medicaments | |
| RU95101048A (ru) | Производные пролинамида, фармкомпозиция на их основе | |
| DE69831868D1 (en) | Antithrombosemittel | |
| HRP20020428B1 (en) | Bicyclic amino acids as pharmaceutical agents | |
| PL344599A1 (en) | Novel cyclosporins | |
| IL133623A0 (en) | Antithrombotic agents | |
| SE9904505D0 (sv) | Novel compounds | |
| EP1193270A3 (en) | Pyrrolobenzodiazepines | |
| AU7415100A (en) | Novel derivatives of dicarboxylic acid having pharmaceutical properties | |
| AU5669398A (en) | Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them | |
| GB0109122D0 (en) | Novel compounds | |
| MX9706605A (es) | Derivados de indol como antagonistas de los aminoacidos exitadores. | |
| AU4770400A (en) | Fused polycyclic amino acids as pharmaceutical agents | |
| EP1019047A4 (en) | ANTITHROMBOTIC AGENTS | |
| TW252979B (enExample) | ||
| AU9270598A (en) | Hydrazono-benzazulene derivatives, pharmaceutical compositions and in termediates | |
| EP0842663A4 (en) | OPHTHALMIC PREPARATIONS | |
| MX9709453A (es) | Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion. | |
| NZ515685A (en) | Use of riluzole for the treatment of multiple sclerosis | |
| EP1027051A4 (en) | ANTITHROMBOTIC AGENTS | |
| GEP20063758B (en) | Benzothia(Dia)Zine Derivatives and Method for Their Use as AMPA Modulators | |
| AU7040398A (en) | Bis-phosphonate confugates with alkylating moieties having antitumor activity | |
| IL134194A0 (en) | Streptogramines, their preparation and compositions containing them | |
| AU3433897A (en) | 2-phenyl-3-azoylbenzothiophene for lowering intraocular pressure | |
| AU1434201A (en) | Antithrombotic agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |